当手术不是一种选择时:在中枢功能障碍的情况下进行过导管内替换的病例报告
Yakup Alsancak1, Hasan Kan2, Ahmet Seyfettin Gürbüz1
1Necmettin Erbakan University, Konya, Turkey.
概括
过导管 mitra 门在门的替换为患有退化的生物假体门的高风险患者提供了一个不那么侵入性的选择. 这一案例证明了成功的植入,解决了心肌吐,改善了患者的功能.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 心脏膜疾病在全球影响超过1亿人,心肌回是常见的.
- 生物假体门在10-15年内退化,需要风险重复的开放心脏手术.
- 过导管 mitra 门内置替换是高风险患者的一种不那么侵入性的替代方案.
研究的目的:
- 报告一个高风险患者成功进行过导管 mitra 门内置换的病例.
- 评估这种微创方法的安全性和有效性.
主要方法:
- 一名69岁的男性患有退化的生物假体关节和高手术风险,接受了手术.
- 一个29毫米的MyVal被植入使用跨septal方法.
- 心声学评估了门功能和血液动力学参数在手术前和后.
主要成果:
- 成功植入了29毫米的MyVal.
- mitra 排泄完全消失,平均梯度显著降低 (13 mmHg 到 3 mmHg).
- 患者在没有并发症的情况下出院,功能能力有所改善 (NYHA第1类).
结论:
- 过导管 mitra 门内置替换是一种可行的和有效的选择,用于生物假体 mitra 门功能障碍的不可操作的患者.
- 用MyVal进行的横septal方法提供了显著的症状和血液动力学改善.
- 这种微创手术技术为重复手术提供了更安全的替代方案,推进了心脏干预.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


